Investigating Disparities in TAVR: Q1 2021- Q1 2024
Toggle navigation
Choose an Outcome
Health Insurance
Comorbidities
Chronic Kidney Disease
NYHA Class
Shared Decision Making
KCCQ-12
Heart Team Reason for Procedure
STS Risk Score
Procedure Status
Non-Femoral Access Sites
Intra- and Post-Procedure Events
Discharge Disposition
Discharge Medications
Rates of Follow-Up
Method of Follow-Up
Living Status at Follow-Up
30-Day Follow-Up Measures
1-Year Follow-Up Measures
30-Day Follow-Up Events
1-Year Follow-Up Events
30-Day Medications
1-Year Medications
KCCQ-12 at Follow-Up
Choose a Variable
None
Age
Sex
Race
Distressed Community
STS Risk
Choose a Summary
All Hospitals
My Hospital
Compare Hospitals V1
Compare Hospitals V2
